You are using an outdated browser. Please upgrade your browser to improve your experience.
CPC Risk Calculator

The Copenhagen Prostate Cancer Center (CPC) Risk Calculator can estimate the individual risk of biochemical recurrence (defined as first ≥PSA 0

The Copenhagen Prostate Cancer Center (CPC) Risk Calculator can estimate the individual risk of biochemical recurrence (defined as first ≥PSA 0

CPC Risk Calculator

by Daman P/S
CPC Risk Calculator
CPC Risk Calculator

What is it about?

The Copenhagen Prostate Cancer Center (CPC) Risk Calculator can estimate the individual risk of biochemical recurrence (defined as first ≥PSA 0.2 ng/ml) after radical prostatectomy for localised prostate cancer. The calculator predicts the absolute risk of biochemical recurrence for the following one- or five years in one-year intervals after surgery. The CPC Risk Calculator has been validated in two large institutional cohorts from Denmark and USA.

CPC Risk Calculator

App Details

Version
1.1
Rating
NA
Size
13Mb
Genre
Medical Utilities
Last updated
December 6, 2016
Release date
January 23, 2016
More info

App Store Description

The Copenhagen Prostate Cancer Center (CPC) Risk Calculator can estimate the individual risk of biochemical recurrence (defined as first ≥PSA 0.2 ng/ml) after radical prostatectomy for localised prostate cancer. The calculator predicts the absolute risk of biochemical recurrence for the following one- or five years in one-year intervals after surgery. The CPC Risk Calculator has been validated in two large institutional cohorts from Denmark and USA.

The dataset is based on 3.746 men who were followed for 20 years after surgery for prostate cancer without receiving any adjuvant treatment at Copenhagen Prostate Cancer Center, Denmark and Stanford Urology, CA, USA. No patients were lost to follow-up. Initial analyses were performed using time between date of surgery and whatever came first biochemical recurrence (outcome of interest) or death without biochemical recurrence (competing risk). Patients without biochemical recurrence were right-censored at latest follow-up. Two multiple cause-specific Cox proportional hazard regression models, one for biochemical recurrence and one for death without recurrence were combined into estimates of the absolute risks of biochemical recurrence. The analyses include preoperative PSA, pT-category, surgical margin status, and radical prostatectomy Gleason score. All analyses were repeated in yearly intervals after surgery using data from patients who survived without biochemical recurrence. The data were internally validated according statistical standards. External validation showed c-index >85% and Brier scores < 5%.

The Copenhagen Prostate Cancer Center is an international research unit affiliated with The Department of Urology at Rigshospitalet, Copenhagen University Hospital, Denmark. Stanford Urology is affiliated with Stanford Medical Center, Stanford, CA, USA.

The statistical model was developed by Prof. Thomas Gerds at The Department of Biostatistics, Faculty of Health and Medical Sciences, University of Copenhagen. The App was developed in collaboration between Andreas Røder (andreasroder@gmail.com) and Daman.dk.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.